LIMANERB Trademark
Trademark Overview
On Wednesday, August 6, 2003, a trademark application was filed for LIMANERB with the United States Patent and Trademark Office. The USPTO has given the LIMANERB trademark a serial number of 78283825. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 15, 2011. This trademark is owned by Glaxo Group Limited. The LIMANERB trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations
General Information
Serial Number | 78283825 |
Word Mark | LIMANERB |
Filing Date | Wednesday, August 6, 2003 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, April 15, 2011 |
Registration Number | 2884314 |
Registration Date | Tuesday, September 14, 2004 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, June 22, 2004 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, April 15, 2011 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Glaxo Group Limited |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Middlesex UB 0NN GB |
Party Name | Glaxo Group Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Middlesex UB 0NN GB |
Party Name | Glaxo Group Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Middlesex UB 0NN GB |
Trademark Events
Event Date | Event Description |
Friday, April 15, 2011 | CANCELLED SEC. 8 (6-YR) |
Thursday, May 13, 2010 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, February 25, 2010 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, February 25, 2010 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, September 14, 2004 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, June 22, 2004 | PUBLISHED FOR OPPOSITION |
Wednesday, June 2, 2004 | NOTICE OF PUBLICATION |
Tuesday, April 13, 2004 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, February 2, 2004 | Sec. 1(B) CLAIM DELETED |
Wednesday, February 4, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, February 4, 2004 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, January 26, 2004 | LETTER OF SUSPENSION E-MAILED |
Monday, January 26, 2004 | ASSIGNED TO EXAMINER |